Homeostatic action of adenosine A3 and A1 receptor agonists on proliferation of hematopoietic precursor cells

Experimental Biology and Medicine

Volumn 233, Issue 7, 2008, Pages 897-900

  Hofer, Mlchal ^a   Pospíšil, Milan ^a   Znojil, Vladimír ^b   Holá, Jiřina ^a   Štreitová, Denisa ^a   Vacek, Antonín ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Adenosine receptors; Cell proliferation; Hematopoiesis

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; FLUOROURACIL; N 6 (3 IODOBENZYL)ADENOSINE 5' N METHYLURONAMIDE; N 6 CYCLOPENTYLADENOSINE; UNCLASSIFIED DRUG; ADENOSINE; DRUG DERIVATIVE; N(6) (3 IODOBENZYL) 5' N METHYLCARBOXAMIDOADENOSINE; N(6) CYCLOPENTYLADENOSINE; N(6)-(3-IODOBENZYL)-5'-N-METHYLCARBOXAMIDOADENOSINE; N(6)-CYCLOPENTYLADENOSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; ERYTHROID CELL; GRANULOCYTE; GRANULOPOIESIS; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; MALE; MOUSE; NONHUMAN; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CBA MOUSE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; PHYSIOLOGY;

MUS;

ADENOSINE; ANIMALS; BONE MARROW CELLS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROID CELLS; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; HOMEOSTASIS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A3;

EID: 47749100459     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0802-RM-43     Document Type: Article

References (21)

1. Abbracchio MP, Burnstock G. Purinergic signalling: Pathophysiological roles. Jap J Pharmacol 78:113-145, 1998.
2. Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Ådén U, Svenningsson P. Adenosine receptor signaling in vitro and in vivo. Drug Develop Res 52:274-282, 2001.
3. Jacobson KA, Gao Z-G. Adenosine receptors as therapeutic targets. Nature Rev Drug Discov 5:247-264, 2006.
4. Schulte G, Fredholm BB. Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signall 15:813-827, 2003.
5. Hofer M, Pospíšil M, Netíková J, Znojil V, Vácha J. Granulocyte colony-stimulating factor and drugs elevating extracellular adenosine act additively to enhance the hemopoietic spleen colony formation in irradiated mice. Physiol Res 48:37-42, 1999.
6. Hofer M, Pospíšil M, Znojil V, Vacek A, Weiterová L, Holá J, Vácha J. Drugs elevating extracellular adenosine promote regeneration of haematopoietic progenitor cells in severely myelosuppressed mice: their comparison and joint effects with the granulocyte colony-stimulating factor. Eur J Haematol 68:4-11, 2002.
7. Pospíšil M, Hofer M, Znojil V, Vácha J, Netíková J, Holá J. Synergistic effect of granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on neutrophil production in mice. Blood 86: 3692-3697, 1995.
8. Pospíšil M, Hofer M, Vacek A, Netíková J, Holá J, Znojil V, Weiterová L. Drugs elevating extracellular adenosine enhance cell cycling of hematopoietic progenitor cells as inferred from the cytotoxic effects of 5-fluorouracil. Exp Hematol 29:557-562, 2001.
9. Bar-Yehuda S, Madi L, Barak D, Mittelman M, Ardon E, Ochaion A, Cohn S, Fishman P. Agonists to the A3 adenosine receptor induce G-CSF production via NF-kB activation: A new class of myeloprotective agents. Exp Hematol 30:1390-1398, 2002.
10. Fishman P, Bar-Yehuda S, Farbstein T, Barer F, Ohana G. Adenosine acts as a chemoprotective agent by stimulating G-CSF production: A role for A1 and A3 adenosine receptors. J Cell Physiol 183:393-398, 2000.
11. 3 receptor agonist on bone marrow granulocytic system in 5-fluorouracil-treated mice. Eur J Pharmacol 538:163-167, 2006.
12. 3 receptor agonist acts as a homeostatic regulator of bone marrow hematopoiesis. Biomed Pharmacother 61:356-359, 2007.
13. Pospíšil M, Hofer M, Vacek A, Znojil V, Pipalová I. Effects of stable adenosine receptor agonists on bone marrow hematopoietic cells as inferred from the cytotoxic action of 5-fluorouracil. Physiol Res 53: 549-556, 2004.
14. 6-cyclopentyladenosine inhibits proliferation of murine hematopoietic progenitor cells in vivo. Eur J Pharmacol 507:1-6, 2005.
15. Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissmann G. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 148:2201-2206, 1992.
16. 3 receptors. Am J Physiol Ren Physiol 278:F380-F387, 2000.
17. Black RG, Guo Y, Ge Z-D, Murphree SS, Prabhu SD, Jones WK, Bolli R, Auchampach JA. Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor. Circ Res 91:165-172, 2002.
18. 1 adenosine receptor ligands. Curr Top Med Chem 3: 369-385, 2003.
19. 3 receptor. FASEB J 12:1785-1792, 1998.
20. 3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. Clin Cancer Res 10:4472-4479, 2004.
21. Nečas E, Š efc L, Brecher G, Bookstein N. Hematopoietic reserve provided by spleen colony-forming units (CFU-S). Exp Hematol 23: 1242-1246, 1995.